Mike McDermott, chief global supply officer and executive vice-president at the pharmaceutical giant, said the company had a very strong development pipeline for new products, which needed flexible facilities.
“Our pipeline is incredibly strong, and we need facilities that can accept that pipeline and are nimble ...
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: